CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM NEW
Total 13F shares
1,660,936
Share change
+41,767
Total reported value
$29,326,496
Price per share
$17.66
Number of holders
35
Value change
+$729,452
Number of buys
17
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q4 2018

As of 31 Dec 2018, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,660,936 shares. The largest 10 holders included BlackRock Inc., Vanguard Group Inc, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Bank of New York Mellon Corp, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, DIMENSIONAL FUND ADVISORS LP, and MORGAN STANLEY. This page lists 35 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.